ad image

Heart Failure

1 / 1
AstraZeneca
Fast Track Designation

FDA Grants Fast Track Designation for Farxiga in Heart Failure

AstraZeneca

PR-M09-19-NI-042Sep 18, 2019
U.S. Food & Drug Administration
FDA Approval

FDA Approves New Device to Improve Symptoms in Patients with Advanced Heart Failure

U.S. Food & Drug Administration

PR-M08-19-NI-055Aug 20, 2019
Eli Lilly and Company
FDA Fast Track

U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure

Eli Lilly and Company

PR-M06-19-NI-058Jun 28, 2019
1 / 1